Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus

Neuroscience

Volumn 77, Issue 1, 1997, Pages 121-130

  Sershen, H ^a   Balla, A ^b   Lajtha, A ^a   Vizi, E S ^b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Hippocampus; Nicotinic acetylcholine receptor; Noradrenaline release; Noradrenergic receptor; Presynaptic receptors; Subtypes

Indexed keywords

NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HIPPOCAMPUS; INTERNEURON; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DENTATE GYRUS; DIMETHYLPHENYLPIPERAZINIUM IODIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; NOREPINEPHRINE; ORGAN CULTURE TECHNIQUES; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; TETRODOTOXIN; TRITIUM;

EID: 0031018352     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00425-3     Document Type: Article

References (50)

1. Alkondon M., Albuquerque E. X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. J. Pharmac. exp. Ther. 265:1993;1455-1473.
2. Boulter J., Connolly J., Deneris E., Goldman D., Heinemann S., Patrick J. Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc. natn. Acad. Sci. U.S.A. 84:1987;7763-7767.
3. Chiou C. Y., Long J. P., Potrepka R., Spratt J. L. The ability of various nicotinic agents to release acetylcholine from synaptic vesicles. Archs int. Pharmacodyn. Thér. 187:1970;88-96.
4. Cimino M., Marini P., Fornasari D., Cattabeni F., Clementi F. Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of alpha 3 subunit mRNA, alpha-bungarotoxin and nicotine binding sites. Neuroscience. 51:1992;77-86.
5. Flores C. M., Rogers S. W., Pabreza L. A., Wolfe B. B., Kellar K. J. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Molec. Pharmac. 41:1992;31-37.
6. Freund R. K., Jungschaffer D. A., Collins A. C. Nicotine effects in mouse hippocampus are blocked by mecamylamine, but not by other nicotinic antagonists. Brain Res. 511:1990;187-191.
7. Gaddum J. H. The quantitative effects of antagonistic drugs. J. Physiol., Lond. 89:1937;7P.
8. 3H-dopamine in rat striatal slices and cat caudate nucleus. Brain Res. 106:1976;117-131.
9. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59:1992;848-856.
10. Grenhoff J., Svensson T. H. Nicotinic and muscarinic components of rat brain dopamine synthesis stimulation induced by physostigmine. Naunyn-Schmiedeberg's Arch. Pharmac. 346:1992;395-398.
11. 3H-NE from hypothalamus. Biochem. Pharmac. 21:1972;1829-1838.
12. 3H-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices. Naunyn-Schmiedeberg's Arch. Pharmac. 296:1977;91-97.
13. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science. 239:1988;57-61.
14. Hortnagl H., Berger M. L., Sperk G., Pifl C. Regional heterogeneity in the distribution of neurotransmitter markers in the rat hippocampus. Neuroscience. 45:1991;261-272.
15. Hunter B. E., de Fibre C. M., Papke R. L., Kem W. R., Meyer E. M. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci. Lett. 168:1994;130-134.
16. Lewis P. R., Shute C. C. D., Silver A. Confirmation from choline acetylase analysis of a massive cholinergic innervation to the rat hippocampus. J. Physiol., Lond. 191:1967;215-224.
17. Loy R., Koziell D. A., Lindsey J. D., Moore R. Y. Noradrenergic innervation of the adult rat hippocampal formation. J. comp. Neurol. 189:1980;699-710.
18. Luetje C. W., Patrick J. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11:1991;837-845.
19. Lukas R. J. Nicotinic acetylcholine receptor diversity: agonist binding and functional potency. Prog. Brain Res. 79:1989;117-127.
20. 3H]acetylcholine binding sites. J. Pharmac. exp. Ther. 253:1990;51-57.
21. Lukas R. J., Bencherif M. Heterogeneity and regulation of nicotinic acetylcholine receptors. Int. Rev. Neurobiol. 34:1992;25-131.
22. Milusheva E., Baranyi M., Zelles T., Mike A., Vizi E. S. Release of acetylcholine and noradrenaline from the cholinergic and adrenergic afferents in rat hippocampal CA1, CA3, and dentate gyrus regions. Eur. J. Neurosci. 6:1994;187-192.
23. Mulle C., Vidal C., Benoit P., Changeux J. P. Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system. J. Neurosci. 11:1991;2588-2597.
24. Oleskevich S., Descarries L., Lacaille J. C. Quantified distribution of the noradrenaline innervation in the hippocampus of adult rat. J. Neurosci. 9:1989;3803-3815.
25. Papke R. L., Duvoisin R. M., Heinemann S. F. The amino terminal half of the nicotinic beta-subunit extracellular domain regulates the kinetics of inhibition by neuronal bungarotoxin. Proc. R. Soc. Lond. Ser. B: Biol. Sci. 252:1993;141-148.
26. Papke R. L., Heinemann S. F. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit. Molec. Pharmac. 45:1994;142-149.
27. Patrick J., Séguéla P., Vernino S., Amador M., Luetje C., Dani J. A. Functional diversity of neuronal acetylcholine receptors. Prog. Brain Res. 98:1993;113-120.
28. Qian G., Li T., Shen T. V., Libertine-Garahan L., Eckman J., Bifta T., Ip S. Epibatidine is a nicotinic analgesic. Eur. J. Pharmac. 250:1993;R13-R14.
29. Rapier C., Lunt G. G., Wonnacott S. Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J. Neurochem. 50:1988;1121-1130.
30. Ropert N., Krnjevic K. Pharmacological characteristics of facilitation of hippocampal population spikes by cholinomimetics. Neuroscience. 7:1982;1963-1977.
31. Rovira C., Ben-Ari Y., Cherubini E., Krnjevic K., Ropert N. Pharmacology of the dendritic action of acetylcholine and further observations on the somatic disinihibition in the rat hippocampus in situ. Neuroscience. 8:1983;97-106.
32. 3H-acetylcholine release from mouse cerebral cortical synaptosomes. J. Neurochem. 43:1984;1593-1598.
33. Rubboli F., Court J. A., Sala C., Morris C., Chini B., Perry E., Clementi F. Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur. J. Neurosci. 6:1994;1596-1604.
34. Rubboli F., Court J. A., Sala C., Morris C., Chini B., Perry E., Clementi F. Distribution of neuronal nicotinic receptor subunits in human brain. Neurochem. Int. 25:1994;69-71.
35. Sacaan A. I., Dunlop J. L., Lloyd G. K. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmac. exp. Ther. 274:1995;224-230.
36. Sandor N. T., Zelles T., Kiss J., Sershen H., Torocsik A., Lajtha A., Vizi E. S. Effect of nicotine on dopaminergic-cholinergic interaction in the striatum. Brain Res. 567:1991;313-316.
37. Sargent P. B. The diversity of neuronal nicotinic acetylcholine receptors. A. Rev. Neurosci. 16:1993;403-443.
38. Scanziani M., Gahwiler B. H., Thompson S. M. Presynaptic inhibition of EPSPs by norepinephrine in the area CA3 of hippocampal slice cultures. Soc. Neurosci. Abstr. 18:1992;791.
39. Scanziani M., Gahwiler B. H., Thompson S. M. Presynaptic inhibition of excitatory synaptic transmission mediated by α adrenergic receptors in area CA3 of the rat hippocampus in vitro. J. Neurosci. 13:1993;5393-5401.
40. Segal M. The acetylcholine receptor in the rat hippocampus; nicotinic, muscarinic or both? Neuropharmacology. 17:1978;619-623.
41. Thomas P., Stephens M., Wilkie G., Amar M., Lunt G. G., Whiting P., Gallagher T., Pereira E., Alkonkon M., Albuquerque E. X., Wonnacott S. (+)-Anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors. J. Neurochem. 60:1993;2308-2311.
42. Thompson S. M., Capogna M., Scanziani M. Presynaptic inhibition in the hippocampus. Trends Neurosci. 16:1993;222-227.
43. Vaughan P. F. T., Kaye D. F., Reeve H. L., Ball S. G., Peers C. Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y. J. Neurochem. 60:1993;2159-2166.
44. Vernallis A. B., Conroy W. G., Berg D. K. Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron. 10:1993;451-464.
45. Vizi E. S. (1984) Non-synaptic Interaction Between Neurons: Modulation of Neurochemical Transmission. Pharmacological and Clinical Aspects. John Wiley, Chichester.
46. Vizi E. S., Balla A., Sershen H., Lajtha A. Characterization of cholinergic receptors involved in facilitation of noradrenaline release from hippocampus. Trans. Am. Soc. Neurochem. 25:1994;364.
47. Vizi E. S., Labos E. Nonsynaptic interactions at presynaptic level. Prog. Neurobiol. 37:1991;145-163.
48. Vizi E. S., Sershen H., Balla A., Mike Á., Windisch K., Jurányi Zs., Lajtha A. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nAChRs. Ann. N. Y. Acad. Sci. 757:1995;84-99.
49. Wada E., Wada K., Boulter E., Deneris E. S., Heinemann S., Patrick J., Swanson L. Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. comp. Neurol. 284:1989;314-335.
50. Young W. S., Kuhar M. J. Noradrenergic α1 and α2 receptors: light microscopic autoradiographic localization. Proc. natn. Acad. Sci. U.S.A. 77:1980;1696-1700.